Cargando…

The Development of an Ontology Platform to Detect Serine Protease Involvement in COVID-19-Induced Co-Morbid BALT Lymphoma

Detalles Bibliográficos
Autores principales:	Leyfman, Yan, Sandeep, Samarth, McGregor, Kirk, Park, Chandler Howard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Online Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665193/ http://dx.doi.org/10.1182/blood-2022-159853

Ejemplares similares

Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies
por: Leyfman, Yan, et al.
Publicado: (2021)

A Case Report on a Chemotherapy Treatment to a SARSCOV2 PCR Positive, Non-Hodgkins Lymphoma Filipino Patient
por: Velasco, Manuel Reyes
Publicado: (2022)

PB2135: BURKITT LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (BL-IPI): IS IT EFFICIENT ENOUGH IN ADULT BURKITT LYMPHOMA PATIENTS?
por: Sayinalp, B., et al.
Publicado: (2022)

PB1872: SELINEXOR IN COMBINATION WITH VENETOCLAX AND HYPOMETHYLATING AGENTS FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE CO-MORBIDITIES
por: Chen, Fangli, et al.
Publicado: (2023)

PB2156: ANALYSIS OF POSSIBLE CLONAL ORIGIN OF LARGE B-CELL DIFFUSED LYMPHOMAS ARISING IN PATIENTS WITH PRE-EXISTING HODGKIN’S LYMPHOMA
por: Masciopinto, P., et al.
Publicado: (2022)

PB2435: ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOMES IN HODGKIN LYMPHOMA: A PROGNOSTIC STUDY OF 30 PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
por: Zamani, Shayan, et al.
Publicado: (2023)

Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection
por: Vegivinti, Charan Thej Reddy, et al.
Publicado: (2022)

Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma
por: Roose, James, et al.
Publicado: (2022)

Patients Experience with Telemedicine during COVID-19 Pandemic in a Tertiary Cancer Center in Qatar
por: Elhakeem, Israa, et al.
Publicado: (2022)

Risk Factors and Outcome of COVID-19 Infection in Haematological Patients : A Multicenter Retrospective Analysis in Malaysia
por: Keat, Sui, et al.
Publicado: (2022)

The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up
por: Ujjani, Chaitra S., et al.
Publicado: (2022)

Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study
por: Yassin, Mohamed A, et al.
Publicado: (2022)

Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients
por: Creeper, Katherine J., et al.
Publicado: (2022)

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma
por: Chaulagain, Chakra P, et al.
Publicado: (2022)

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
por: Thalambedu, Nishanth, et al.
Publicado: (2022)

Hemophagocytic Lymphohystiocytosis in a Patient with Post-Acute COVID-19 Infection
por: Mohamed Jiffry, Mohamed Zakee, et al.
Publicado: (2022)

Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia
por: Passerini, Matteo, et al.
Publicado: (2022)

Real World Favourable Experience of Haematopoietic Stem Cell Transplantation during Acute Coronavirus Disease 2019 in a Highly-Vaccinated Asian Population
por: Tham, Christopher, et al.
Publicado: (2022)

Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres
por: Innocenti, Idanna, et al.
Publicado: (2022)

The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19
por: Nishikubo, Masashi, et al.
Publicado: (2022)

Mortality of COVID-19 in Patients with Hematological Malignancies Versus Solid Tumors: A Systematic Literature Review and Meta-Analysis
por: Vegivinti, Charan Thej Reddy, et al.
Publicado: (2022)

Immune Thrombocytopenia Purpura Relapse in Patients Who Received mRNA COVID-19 Vaccines
por: Qasim, Hana, et al.
Publicado: (2022)

Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
por: Pedraza, Alexandra, et al.
Publicado: (2022)

COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura
por: Sharawi, Said, et al.
Publicado: (2022)

A Case Series of Immune Flare and Lupus Anticoagulant Following COVID-19 Vaccination
por: Cherabuddi, Medha Reddy, et al.
Publicado: (2022)

Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events
por: Hussain, Mushtaq, et al.
Publicado: (2022)

Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study
por: Miranda, Marisol, et al.
Publicado: (2022)

COVID-19 Associated Atypical Hemolytic Uremic Syndrome
por: Shan Ul Abedin, Muhammad, et al.
Publicado: (2022)

Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT)
por: Tariq, Anosha, et al.
Publicado: (2022)

The Use of Convalescent Plasma Therapy on COVID-19 Filipino Patients: A Tertiary Center Experience
por: Velasco, Manuel Reyes, et al.
Publicado: (2022)

Characterisation of Platelet Sensitivity in Severe COVID-19
por: Saputil, Rocel C., et al.
Publicado: (2022)

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
por: Valsecchi, Carla, et al.
Publicado: (2022)

Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center
por: Mourão Toreli, Ana Carolina, et al.
Publicado: (2022)

Prediction of Outcome in Hospitalized Patients with COVID-19: Development of a COVID-19 Scoring Prognostic Model
por: Raman, Ganesh, et al.
Publicado: (2022)

Assessing Immune Response to 3(rd) Dose of COVID-19 Vaccine Series in Patients Undergoing Cancer Treatment at University Medical Center- New Orleans
por: Nguyen, Anh Q., et al.
Publicado: (2022)

COVID-19 in Adults with Sickle Cell Disease: Data from Cerner Real-World Database
por: Guarino, Stephanie H, et al.
Publicado: (2022)

PB2334: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
por: Aggarwal, S., et al.
Publicado: (2022)

PB2093: DIFFUSE LARGE B CELL LYMPHOMA IN THE ELDERLY
por: Abichou, G., et al.
Publicado: (2022)

PB2369: PERIPHERAL T CELL LYMPHOMA: EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS
por: Charfi, Maha, et al.
Publicado: (2023)

PB2291: EFFICACY OF SPLENECTOMY IN SPLENIC MARGINAL ZONE LYMPHOMA
por: Yevstakhevych, Yuriy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_94ubltqvhd341rd7petasahnij